Alliancebernstein L.P. Catalyst Biosciences, Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$7.08 - $10.6 $96,996 - $145,220	-13,700 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$7.67 - $9.96 $25,311 - $32,868	-3,300 Reduced 19.41%	13,700 $111,000
Q2 2018 Aug 13, 2018	BUY	$9.11 - $28.88 $154,870 - $490,960	17,000 New	17,000 $198,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.